Molecular diagnosis of bloodstream infections: Planning to (physically) reach the bedside

Current Opinion in Infectious Diseases

Volumn 23, Issue 4, 2010, Pages 311-319

  Leggieri, N ^a   Rida, A ^b   Francois P ^a   Schrenzel, Jacques ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Spinomix SA   (Switzerland)

Author keywords

broad range PCR; molecular identification; PCR whole blood; rapid identification; realtime PCR

Indexed keywords

AMPLICON; BACTERIUM CULTURE; BACTERIUM ISOLATION; BLOOD CULTURE; BLOODSTREAM INFECTION; DIAGNOSTIC PROCEDURE; GEL ELECTROPHORESIS; HUMAN; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROARRAY ANALYSIS; NONHUMAN; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; BACTEREMIA; BACTERIUM IDENTIFICATION; HOSPITAL INFORMATION SYSTEM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR DIAGNOSIS; POLYMERASE CHAIN REACTION; PROCEDURES; TIME; TRENDS;

BACTERIAL DNA;

BACTEREMIA; BACTERIAL TYPING TECHNIQUES; DNA, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES; POINT-OF-CARE SYSTEMS; POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 77954875923     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32833bfc44     Document Type: Review

References (50)

1. Rello J, Sa-Borges M, Correa H, et al. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999; 160:608-613.
2. Harbarth S, Garbino J, Pugin J, et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115:529-535.
3. Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146-155.
4. Kumar A, Ellis P, Arabi Y, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009; 136:1237-1248.
5. Valles J, Rello J, Ochagavia A, et al. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 2003; 123:161 5-1624.
6. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-1596.
7. Murray P, Baron EJ, Jorgensen J, et al. Manual of clinical microbiology. 9th ed. Washington, District of Columbia: American Society of Microbiology; 2007.
8. Cherkaoui A, Hibbs J, Emonet S, et al. Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level. J Clin Microbiol 2010; 48:1169-1175.
9. Stevenson LG, Drake SK, Murray PR. Rapid identification of bacteria in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2010; 48:444-447.
10. Prod?hom G, Bizzini A, Durussel C, et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for direct bacterial identification from positive blood culture pellets. J Clin Microbiol 2010; 48:1481-1483.
11. Sachse S, Straube E, Lehmann M, et al. Truncated human cytidylate-phos-phate-deoxyguanylate-binding protein for improved nucleic acid amplification technique-based detection of bacterial species in human samples. J Clin Microbiol 2009; 47:1050-1057.
12. Gebert S, Siegel D, Wellinghausen N. Rapid detection of pathogens in blood culture bottles by real-time PCR in conjunction with the preanalytic tool MolYsis. J Infect 2008; 57:307-316.
13. Tissari P, Zumla A, Tarkka E, et al. Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study. Lancet 2010; 375:224-230.
14. Wellinghausen N, Kochem AJ, Disque C, et al. Diagnosis of bacteremia in whole-blood samples by use of a commercial universal 16S rRNA gene-based PCR and sequence analysis. J Clin Microbiol 2009; 47:2759-2765.
15. Ecker DJ, Sampath R, Massire C, et al. Ibis T5000: a universal biosensor approach for microbiology. Nat Rev Microbiol 2008; 6:553-558.
16. Sampath R, Hall TA, Massire C, et al. Rapid identification of emerging infectious agents using PCR and electrospray ionization mass spectrometry. Ann N Y Acad Sci 2007; 1102:109-120.
17. Seng P, Drancourt M, Gouriet F, et al. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 2009; 49:543-551.
18. Wallet F, Nseir S, Baumann L, et al. Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood. Clin Microbiol Infect 2009; 16:774-779.
19. Avolio M, Diamante P, Zamparo S, et al. Molecular identification of blood stream pathogens in patients presenting to the emergency room with suspected sepsis. Shock 2010 [Epub ahead of print].
20. Lehmann LE, Alvarez J, Hunfeld KP, et al. Potential clinical utility of polymerase chain reaction in microbiological testing for sepsis. Crit Care Med 2009; 37:3085-3090.
21. Bloos F, Hinder F, Becker K, et al. A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis. Intensive Care Med 2010; 36:241-247.
22. Dierkes C, Ehrenstein B, Siebig S, et al. Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis. BMC Infect Dis 2009; 9:126.
23. Louie RF, Tang Z, Albertson TE, et al. Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia. Crit Care Med 2008; 36:1487-1492.
24. Mancini N, Clerici D, Diotti R, et al. Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies. J Med Microbiol 2008; 57:601-604.
25. Tsalik EL, Jones D, Nicholson B, et al. Multiplex PCR to diagnose bloodstream infections in patients admitted from the emergency department with sepsis. J Clin Microbiol 2010; 48:26-33.
26. Harbarth S, Masuet-Aumatell C, Schrenzel J, et al. Evaluation of rapid screening and preemptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Crit Care 2006; 10:R25.
27. Iregui M, Ward S, Sherman G, et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002; 122:262-268.
28. Bouza E, Sousa D, Munoz P, et al. Bloodstream infections: a trial of the impact of different methods of reporting positive blood culture results. Clin Infect Dis 2004; 39:1161-1169.
29. O'Farrell B, Bauer J. Developing highly sensitive, more-reproducible lateral-flow assays. Part 2: New approaches to old problems. IVD Technology 1 July 2006.
30. O?farrell B, Bauer J. Developing highly sensitive, more-reproducible lateral-flow assays. Part 1: new approaches to old problems. IVD Technology 1 June 2006. Nanosphere Inc. http://www.nanosphere.us/.
31. Zakroff J. New test offers fresh hope for POC testing. IVD Technology 1 November 2004.
32. Nam JM, ParkSJ, MirkinCA. Bio-barcodes based onoligonucleotide-modified nanoparticles. J Am Chem Soc 2002; 124:3820-3821.
33. Nam JM, Stoeva SI, Mirkin CA. Bio-bar-code-based DNA detection with PCR-like sensitivity. J Am Chem Soc 2004; 126:5932-5933.
34. Park SJ, Taton TA, Mirkin CA. Array-based electrical detection of DNA with nanoparticle probes. Science 2002; 295:1503-1506.
35. Kersten DJ, Henle-Gross A, Droz S, et al. The proof of B-Streptococcus in comparison: culture (Goldstandard) versus GeneXpert GBS (PCR-Schnellt-est). Geburtsh Frauenheilk 2008; 68:S126.
36. Parta M, Goebel M, Matloobi M, et al. Identification of methicillin-resistant or methicillin-susceptible Staphylococcus aureus in blood cultures and wound swabs by GeneXpert. J Clin Microbiol 2009; 47:1609-1610.
37. Anonymous. Cepheid granted US patent covering GeneXpert (R) cartridge: key patent enables fully automated sample preparation for DNA testing. Mol Biotechnol 2002; 22:213-214.
38. Kiechle FL, Holland CA. Point-of-care testing and molecular diagnostics: miniaturization required. Clin Lab Med 2009; 29:555.
39. Yager P, Domingo GJ, Gerdes J. Point-of-care diagnostics for global health. Annu Rev Biomed Eng 2008; 10:107-144.
40. Cady NC, Stelick S, Batt CA. Nucleic acid purification using microfabricated silicon structures. Biosens Bioelectron 2003; 19:59-66.
41. Breadmore MC, Wolfe KA, Arcibal IG, et al. Microchip-based purification of DNA from biological samples. Anal Chem 2003; 75:1880-1886.
42. Lee AP. Cutting edge: microfluidic-micromagnetic blood cleansing device. Lab Chip 2009; 9:1167.
43. Yung CW, Fiering J, Mueller AJ, Ingber DE. Micromagnetic-microfluidic blood cleansing device. Lab Chip 2009; 9:1171-1177.
44. Unkmeir A, Kammerer U, Stade A, et al. Lipooligosaccharide and polysac-charide capsule: virulence factors of Neisseria meningitidis that determine meningococcal interaction with human dendritic cells. Infect Immun 2002; 70:2454-2462.
45. Tuomanen E, Tomasz A, Hengstler B, Zak O. The relative role of bacterial-cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J Infect Dis 1985; 151:535-540.
46. White JG. Why human platelets fail to kill bacteria. Platelets 2006; 17:191-200.
47. Clawson CC, White JG. Platelet interaction with bacteria II. Fate of bacteria. Am J Pathol 1971; 65:381.
48. Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol 2006; 4:445-457.
49. Fautstich K, Gruler R, Eberhard M, Haberstroh K. Developing rapid mobile POC systems. IVD Technology 1 July 2007.
50. Wilson S, Banin S, Stanley C. Detecting ATP with nucleic acid amplification. IVD Technology 1 November 2007.